| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer
1 company
Dylan-Hyde Tyler is a Chief Legal Officer at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 25 sells.
Estimated insider holdings value: $1.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2018 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sale+OE | 66,000 | $28.03 | $1,850,255.40 | -46.6% | |
| Jan 2, 2018 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sale+OE | 38,000 | $21.64 | $822,500.00 | -21.3% | |
| Dec 29, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sale+OE | 31,000 | $22.72 | $704,280.00 | -5.2% | |
| Dec 22, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sell | 15,000 | $20.55 | $308,250.00 | -11.5% | |
| Dec 15, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sell | 15,000 | $18.90 | $283,495.50 | -10.3% | |
| Aug 8, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sell | 15,000 | $18.57 | $278,479.19 | -3.1% | |
| May 1, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sell | 1,852 | $16.61 | $30,753.39 | -1.1% | |
| Apr 28, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sell | 21,639 | $16.78 | $363,077.31 | -4.0% | |
| Apr 25, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sell | 11,332 | $16.78 | $190,109.40 | -2.0% | |
| Apr 20, 2017 | CRSP Crispr Therapeutics AG | Chief Legal Officer | Sell | 10,177 | $17.71 | $180,190.09 | -1.7% |